In 2014, MAPS spun out a separate division to immediate analysis and get ready for an eventual FDA software, which it submitted at the end of final calendar year. In early 2024, that offshoot was renamed Lykos Therapeutics.In 1938, since the now common story goes, the Swiss chemist Albert Hofmann was Doing the job to the Sandoz corporation, a pharm